METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR DEVELOPING COST-EFFECTIVE, EVIDENCE-BASED TREATMENT PATHWAYS USING A DATA-DRIVEN APPROACH

• US 20120239410A1
• Filed: 03/17/2011
• Published: 09/20/2012
• Est. Priority Date: 03/17/2011
• Status: Abandoned Application

• Current Assignee: Onmark, Inc. (McKesson Corp.)
• Original Assignee: Onmark, Inc. (McKesson Corp.)
• Inventors: Bergstrom, Kim, Tom, Brandon, Verrilli, Diana
• Application Number:
  US13/049,971
• Publication Number:
  US 20120239410A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage
• CPC Class Codes: G16H 70/60 relating to pathologies

Abstract

A method for developing cost-effective, evidence-based treatment pathways using a data driven approach may include receiving information indicative of prescribing patterns associated with one or more drug regimens employed by an organization for treatment of a disease, receiving information indicative of financial performance of the one or more drug regimens, receiving information indicative of clinical efficacy of the one or more drug regimens, and enabling development of a treatment pathway based on the information received indicative of financial performance and clinical efficacy. A corresponding computer program product and apparatus are also provided.

Claims

1. A method comprising:

receiving information indicative of prescribing patterns associated with one or more drug regimens employed by an organization for treatment of a disease;

receiving information indicative of financial performance of the one or more drug regimens;

receiving information indicative of clinical efficacy of the one or more drug regimens; and

enabling, via processing circuitry, development of a treatment pathway based on the information received indicative of financial performance and clinical efficacy.

2. The method of claim 1, wherein enabling development of the treatment pathway comprises enabling designation of one or more selected regimens for inclusion in a standardized treatment pathway to be employed by the organization.

3. The method of claim 1, further comprising enabling generation of a report indicative of analysis of financial performance or clinical efficacy of one or more drug regimens via a dashboard.

4. The method of claim 1, further comprising providing monitoring of prescribing activities within the organization to determine adherence with respect to utilization of one or more standardized regimens identified as selected treatment pathways.

5. The method of claim 1, wherein receiving information indicative of prescribing patterns associated with one or more drug regimens employed by the organization comprises receiving data indicative of national guidelines associated with treatment of the disease.

6. The method of claim 5, wherein enabling development of the treatment pathway comprises enabling generation of a report benchmarking the treatment pathway relative to the national guidelines.

7. The method of claim 1, wherein enabling development of the treatment pathway comprises enabling generation of a report indicating a forecast of treatment cost or reimbursement amounts associated with the treatment pathway.

8. An apparatus comprising processing circuitry configured to:

receive information indicative of prescribing patterns associated with one or more drug regimens employed by an organization for treatment of a disease;

receive information indicative of financial performance of the one or more drug regimens;

receive information indicative of clinical efficacy of the one or more drug regimens; and

enable development of a treatment pathway based on the information received indicative of financial performance and clinical efficacy.

9. The apparatus of claim 8, wherein the processing circuitry being configured to enable development of the treatment pathway comprises the processing circuitry being configured to enable designation of one or more selected regimens for inclusion in a standardized treatment pathway to be employed by the organization.

10. The apparatus of claim 8, wherein the processing circuitry is further configured to enable generation of a report indicative of analysis of financial performance or clinical efficacy of one or more drug regimens via a dashboard.

11. The apparatus of claim 8, wherein the processing circuitry is further configured to provide monitoring of prescribing activities within the organization to determine adherence with respect to utilization of one or more standardized regimens identified as selected treatment pathways.

12. The apparatus of claim 8, wherein the processing circuitry being configured to receive information indicative of prescribing patterns associated with one or more drug regimens employed by the organization comprises the processing circuitry being configured to receive data indicative of national guidelines associated with treatment of the disease.

13. The apparatus of claim 12, wherein the processing circuitry being configured to enable development of the treatment pathway comprises the processing circuitry being configured to enable generation of a report benchmarking the treatment pathway relative to the national guidelines.

14. The apparatus of claim 9, wherein the processing circuitry being configured to enable development of the treatment pathway comprises the processing circuitry being configured to enable generation of a report indicating a forecast of treatment cost or reimbursement amounts associated with the treatment pathway.

15. A computer program product comprising at least one computer-readable storage medium having computer-executable program code instructions stored therein, the computer-executable program code instructions comprising program code instructions for:

receiving information indicative of prescribing patterns associated with one or more drug regimens employed by an organization for treatment of a disease;

receiving information indicative of financial performance of the one or more drug regimens;

receiving information indicative of clinical efficacy of the one or more drug regimens; and

enabling development of a treatment pathway based on the information received indicative of financial performance and clinical efficacy.

16. The computer program product of claim 15, wherein program code instructions for enabling development of the treatment pathway include instructions for enabling designation of one or more selected regimens for inclusion in a standardized treatment pathway to be employed by the organization.

17. The computer program product of claim 15, wherein program code instructions for enabling development of the treatment pathway include instructions for enabling generation of a report indicative of analysis of financial performance or clinical efficacy of one or more drug regimens via a dashboard.

18. The computer program product of claim 15, further comprising program code instructions for providing monitoring of prescribing activities within the organization to determine adherence with respect to utilization of one or more standardized regimens identified as selected treatment pathways.

19. The computer program product of claim 15, wherein program code instructions for receiving information indicative of prescribing patterns associated with one or more drug regimens employed by the organization include instructions for receiving data indicative of national guidelines associated with treatment of the disease.

20. The computer program product of claim 19, wherein program code instructions for enabling development of the treatment pathway include instructions for enabling generation of a report benchmarking the treatment pathway relative to the national guidelines.

21. The computer program product of claim 15, wherein program code instructions for enabling development of the treatment pathway include instructions for enabling generation of a report indicating a forecast of treatment cost or reimbursement amounts associated with the treatment pathway.